Background: We conducted a systematic review and meta-analysis to examine the feasibility
of paclitaxel-coated balloon (PCB) angioplasty for de novo lesions in patients with acute …

BMS strategy (in a reverse order compared to that reported by the PEBSI Study) on de novo
coronary lesions compared to that of BMS and the first-generation (1st-G) paclitaxel-eluting …

Objectives The randomized REVELATION (REVascularization With PaclitaxEL-Coated
Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION) trial …

Background Paclitaxel-coated balloon (PCB) angioplasty in small vessel de novo lesions
has favourable outcome and appears to be an alternative to stent implantation. However …

We retrospectively examined the feasibility of paclitaxel-coated balloon (PCB) angioplasty
for de novo stenosis in large coronary vessels (LV; pre-or postprocedural reference vessel …

Objectives The aim of this single center all‐comers retrospective registry study was to
assess the efficacy and safety of percutaneous coronary intervention (PCI) using drug …

Objectives: This study sought to assess the efficacy and safety of a drug-coated balloon
(DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary …

Background Although use of sirolimus‐based analogs has shown superiority over paclitaxel
in drug‐eluting stents, the relative efficacy of these two agents released from drug‐coated …

Background Primary percutaneous coronary intervention (pPCI) with drug-eluting stents
(DES) has emerged as the standard of care, but stent-related events have persisted. Drug …

Abstract Background Drug-coated balloons (DCBs) are an established strategy for coronary
artery disease. However, the new generation drug-eluting stent (DES) is recommended for …